A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT06045221
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Orforglipron — DRUGAdministered orally
- Semaglutide — DRUGAdministered orally
Study Details
The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.
Key Dates
- Start date
- Sep 22, 2023
- Status verified
- Sep 2025
- Primary completion
- Aug 22, 2025
- Completion
- Aug 22, 2025
Study Design
- Enrollment
- 1,698 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Orforglipron Dose 1Participants will receive orforglipron orally.
- Experimental: Orforglipron Dose 2Participants will receive orforglipron orally.
- Active Comparator: Semaglutide Dose 1Participants will receive semaglutide orally.
- Active Comparator: Semaglutide Dose 2Participants will receive semaglutide orally.
Primary Outcome Measure
Change from Baseline in Hemoglobin A1c (HbA1c) [ Time Frame: Baseline, Week 52 ]
Locations (64)
Related coverage on Hipa.ai
- Orforglipron Phase 3 Trial for Type 2 Diabetes Reaches Primary CompletionOrforglipron · Aug 22, 2025 · ClinicalTrials.gov
Find similar trials in Phoenix, AZ
By condition
By specialty
By research site
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- Sleep and Glycemic Control in Type 2 Diabetes AdolescentsRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Brown Adipose Tissue Activation by Spinal Cord StimulationRecruiting · Oregon Health and Science University · Portland, Oregon